drugset / Trial / NCT00335010

Intravenous NTG to Preserve Gastric Microcirculation During Gastric Tube Reconstruction

NCT00335010 ↗

Completed 32 enrolled Erasmus Medical Center
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of the present study was to investigate if NTG, administered intravenously during gastric tube reconstruction, could preserve gastric fundus tissue blood flow and oxygenation and reduce the incidence of postoperative leakage.

Timeline

Start
2005-05
Primary completion
—
Completion
2005-12

Outcome

Missed primary endpoint

paper MBF and microvascular haemoglobin oxygen saturation decreased similarly in both groups during gastric tube reconstruction and were comparable. PMID 16970804 ↗

paper Under stable systemic haemodynamic conditions, continuous intravenous administration of nitroglycerin could not prevent deterioration in gastric microvascular perfusion and microvascular haemoglobin saturation during gastric tube reconstruction. PMID 16970804 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitroglycerin Unknown — Intravenous

Indications